Biomolecules & Biomedicine (Jul 2024)

Histopathologic degenerative score as a predictor of minimal clinically important difference in pain and functionality following surgical treatment for disc herniation

  • Hakija Bečulić,
  • Emir Begagić,
  • Sabina Šegalo,
  • Fatima Juković Bihorac,
  • Emsel Papić,
  • Ragib Pugonja,
  • Amina Džidić Krivić,
  • Adem Nuhović,
  • Goran Lakičević,
  • Semir Vranić,
  • Mirza Pojskić

DOI
https://doi.org/10.17305/bb.2024.10877

Abstract

Read online

Lumbar disc herniation (LDH) often results in significant pain and disability, and histopathologic evaluation of intervertebral discs offers critical insights into treatment outcomes. This prospective observational study explores histopathologic (HP) changes in intervertebral discs (IVD) and their association with clinical outcomes following surgical treatment for lumbar disc herniation (LDH). A cohort of 141 patients undergoing MRI-confirmed LDH surgery underwent HP evaluation using a semi-quantitative Histopathologic Degeneration Score (HDS). Preoperatively and at a six-month follow-up, comprehensive clinical assessment included the Oswestry Disability Index (ODI) and Visual Analog Scale (VAS), with a minimal clinically important difference (MCID) calculated from ODI and VAS. Results indicated significant associations between higher HDS and adverse clinical outcomes, including persistent pain and greater disability post-surgery. Specifically, an HDS ≥ 7 was predictive (OR = 6.25, CI: 2.56-15.23) of disability outcomes measured with MCID-ODI (AUC: 0.692, CI: 0.609-0.767, P < 0.001), and HDS ≥ 8 was predictive (OR = 1.72, CI: 1.04-2.77) of persistent pain measured with MCID-VAS (AUC = 0.628, CI: 0.598-0.737, P = 0.008), highlighting the diagnostic potential of HDS in assessing postoperative recovery. This study underscores the potential of HP evaluation using HDS to provide valuable insights into disease progression and outcomes in LDH patients, complementing conventional radiologic methods. The findings support the application of personalized treatment strategies based on HP findings while acknowledging challenges in interpretation and clinical implementation.

Keywords